Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning. 1996

J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
Buffalo Psychiatric Center, New York 14213, USA.

OBJECTIVE The long-term effects of a combination of clozapine and psychosocial treatment were evaluated in a sample of treatment-refractory state hospital patients with schizophrenia. METHODS A repeated-measure design was used. Thirty-one patients with schizophrenia received both clozapine and an enhanced psychosocial treatment program. Data were collected at baseline and at one-year, two-year, and three-year follow-ups. Psychiatric symptoms, cognitive functioning, dyskinetic movements, and discharge rate were evaluated. RESULTS Significant reductions in psychiatric symptoms and improvement in cognitive functioning were found. Differences in the pattern of reductions in positive and negative symptoms over the course of the study were noted. The majority of subjects improved sufficiently to be discharged. CONCLUSIONS Clozapine, when combined with psychosocial treatment, is effective for treatment of patients with schizophrenia who are not responsive to other medications.

UI MeSH Term Description Entries
D008134 Long-Term Care Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care. Care, Long-Term,Long Term Care
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
July 2023, Schizophrenia (Heidelberg, Germany),
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
February 1995, Psychopharmacology,
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
February 2022, Psychological medicine,
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
July 2011, Journal of child neurology,
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
May 2001, Journal of the American Academy of Child and Adolescent Psychiatry,
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
July 2004, Journal of child psychology and psychiatry, and allied disciplines,
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
November 1993, Biological psychiatry,
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
January 2014, PloS one,
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
November 2011, Psychiatry research,
J Grace, and S B Bellus, and M L Raulin, and M I Herz, and B L Priest, and V Brenner, and K Donnelly, and P Smith, and S Gunn
October 2016, Psychiatry research,
Copied contents to your clipboard!